Among them, S100A8 and NLRC4 have previously been implicated in GVHD pathogenesis[25, 26] whereas FCER1G and PLA2G4A are known to participate in innate immune activation and inflammatory signaling[27, 28] (Figure 3B). The gene discussed is S100A8; the disease is graft versus host disease.